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A search for new MRI criteria for dissemination
in space in subjects with a clinically isolated
syndrome
Abstract The International Panel on
theDiagnosisofMultipleSclerosis(MS)
incorporated the Barkhof/Tintoré (B/T)
magnetic resonance criteria into their
diagnostic scheme to provide evidence
of dissemination in space of central
nervous system lesions, a prerequisite
for diagnosing MS in patients who
present with clinically isolated syn-
dromes(CIS).AlthoughspecificforMS,
the B/T criteria were criticised for their
low sensitivity and relative complexity
in clinical use. We used lesion charac-
teristicsatonsetfrom349CISpatientsin
logistic regression and recursive parti-
tioning modelling in a search for simpler
and more sensitive criteria, while main-
taining current specificity. The resulting
models, all based on the presence of
periventricular and deep white matter
lesions, performed roughly in agreement
with the B/T criteria, but were unable to
provide higher diagnostic accuracy
based on information from a single scan.
Apparently, findings from contrast-
enhanced and follow-up magnetic
resonance scans are needed to improve
the diagnostic algorithm.
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Magnetic resonance imaging (MRI) is often used to
support the diagnosis of multiple sclerosis (MS). The
McDonald International Panel (IP) on the diagnosis of
multiple sclerosis incorporated the Barkhof/Tintoré MRI
criteria into their diagnostic scheme to gather specific and
objective evidence of dissemination in space of central
nervous system lesions [1]. Additionally, the IP formulated
criteria for the use of MRI to demonstrate dissemination in
time, allowing for an earlier diagnosis of MS to be made in
patients with a clinically isolated syndrome (CIS).
The Barkhof/Tintoré (B/T) criteria for dissemination in
space consist of four individual MRI criteria including one
or more juxtacortical lesions, one or more enhancing
lesions, one or more infratentorial lesions and three or more
periventricular lesions. A threshold is set as at least three
positive criteria with the possibility to substitute the need
for an enhancing lesion with nine or more T2 lesions [2, 3].
The four individual criteria were derived using logistic
regression in a sample of 74 CIS patients, predicting
the development of clinically definite multiple sclerosis
(CDMS) with increasing risk as more criteria were fulfilled
[2]. The threshold, or dichotomisation, at three criteria and
the possibility to substitute an enhancing lesion were
determined in another sample of 70 CIS patients [3].
The choice of the cutoff criterion in the B/T criteria was
fuelled by a desire to maximise specificity, and this was the
reason for incorporation into the IP criteria. Further
validation studies have confirmed the high specificity, but
also revealed the low sensitivity of the B/T criteria for
dissemination in space [4]. Related to this low sensitivity,
the IP criteria have been criticised for being overly
restrictive, preventing an appropriate diagnosis from being
made [5]. Another drawback of the B/T criteria is their
relative complexity, requiring the user to have experience
before using them reliably in a clinical setting [6].
In this study we sought to increase the accuracy and
usability of the current B/Tcriteria by redefining prediction
models based on the predictive properties of a single MRI
examination at onset of CIS. We made use of more
sophisticated statistical methods and took advantage of the
large MAGNIMS database.
Materials and methods
The dataset from the MAGNIMS multicentre follow-up
study was used containing regional brain lesion counts of
initial MRI examinations at onset of CIS and the clinical
follow-upof532patients(fordetailsseeKortewegetal.2006
[4]). From this dataset the 349 cases with a minimal clinical
follow-up of 2 years were selected to allow conversion to
CDMS. The MRI lesions scored included those needed for
the B/T criteria, i.e. number of juxtacortical, periventricular,
deep white matter, enhancing and infratentorial lesions. In
addition, the following items were scored: the number of
corpus callosum, basal ganglia, temporal, brainstem and
cerebellar lesions, the number of hypointense lesions and the
number of lesions bigger than 5 mm. During clinical follow-
up, the occurrence of a second clinical event was assessed,
indicating the development of CDMS [7]. Because of the
retrospective nature of this study, contrast-enhanced scans
were not systematically available, and to prevent selection
bias these lesions were left out of the analysis.
Statistical analysis
To ensure independent exploration and validation of
prediction models, the whole dataset was randomly divided
(2:1) into a training (230 observations) and a test set (119
observations). Two approaches to create a prediction model
for conversion to CDMS were evaluated. In the first
approach logistic regression was used, modelling all MRI
itemsasindependentvariableswithconversiontoCDMSas
adependentvariable.Usingforwardandbackwardstepwise
analysis in the training set (Wald statistic with P value for
entry of 0.05 and a P value for removal of 0.10), the relative
contribution of individual MRI items was assessed for
predicting conversion to CDMS. The items with the highest
contribution were selected to build a regression model,
using ROC (receiver operating characteristic) curves to
determine the optimal cutoff point for dichotomisation of
the continuous covariates. The resulting model was applied
to the test set to calculate the sensitivity and specificity.
In the second approach a multivariate statistical metho-
dology, recursive partitioning, was used to classify cases as
either CIS or CDMS. Recursive partitioning splits the data
into segments that are as homogeneous as possible with
respect to the dependent variable. The method is non-
parametric and non-linear in nature, imposing no implicit
assumption regarding the relation between the predictor
variablesandthedependentvariable.Ateachstep,arecursive
partitioning procedure determines for each variable a cutoff
that optimally splits all of the cases into CIS and CDMS and
selects the variable that performs best. It then takes the
resulting subpopulations and repeats the process, until no
additional partitioning is necessary: either a subpopulation
containsoneclassofcasesorthesubpopulationistoosmallto
be divided. The final results can be summarised in a series of
logical if-then conditions or a decision tree. Additionally, to
overcome the decision tree instability, an analysis was
performed using Random Forest, proposed by Breiman [8].
This method uses bootstrapping to construct multiple inde-
pendent decision trees, each constructed with a random
subset of the predictor variables. In the end, a simplemajority
vote from all trees is taken for prediction.
The program RPART, freely available on the Internet,
implemented in the R language, was used to generate a
decision tree depicting the classification rules generated
through recursive partitioning. When growing the tree, we
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a n de q u a lm i s c l a s s i f i c a t i o nc o s t sf o rC I Sa n dC D M S .T h e
method used to measure impurity (homogeneity) was based
on Gini. Pruning the tree (to correct for overtraining) was
undertaken using the 1-standard error (SE) rule described by
Breiman et al. [9]. Similar to the first approach, the decision
tree was developed in the training set and evaluated using the
test set. All analyses were performed using SPSS 11.04 for
Apple Macintosh, R version 2.5.1 for Apple Macintosh
including RPART 3.1–38 and Random Forest 4.5–19.
Results
Theclinicalcharacteristicsofthecasesincluded(n=349)are
shown in Table 1. The MRI was performed within 3 months
after the onset of CIS, and the mean clinical follow-up time
was 4.9 years (SD 1.9), ranging from 1 to 10 years. During
follow-up, CDMS was diagnosed in 132 cases (37.8%) after
am e d i a nt i m et oc o n v e r s i o no f1 4m o n t h s( I Q R7 . 6 –33.6)
within this group. Those patients converting showed a
median of 11 T2 lesions (IQR 3–22) versus a median of 1
lesions (IQR 0–9) in the non-converted group. Conversion
occurred in 17 of 113 cases (15.0%) without any abnor-
malities at MRI examination.
Forward stepwise regression analysis with the continuous
MRI covariates in the training set found a significant
contribution of deep white matter (B=0.082, p=0.04) and
periventricular (B=0.055, p<0.01) lesions for predicting
conversion to CDMS. The backward stepwise regression
confirmed the importance of these covariates without any
significant contribution of other covariates. The number of
lesionsshowingthehighestaccuracyforpredictingCDMSfor
periventricular and deep white matter lesions was determined
using ROC curves, resulting in three lesions for deep white
matter and two for periventricular lesions. A dichotomised
model was built using these cutoffs and applied in the test
dataset.Thismodelshowedsensitivityof0.43(95%CI:0.28–
0.59),specificity of 0.82 (95%CI:0.71–0.90) andaccuracy of
0.68 (95% CI: 0.59–0.76). An additional analysis including
the age and symptoms at onset in the stepwise regression
analysis revealed no significant contribution of these
covariates to the model. Furthermore, when added to the
analysis, the total number of brain lesions was found to be a
single significant covariate predicting conversion, replacing
the periventricular and deep white matter lesions.
The classification tree analysis included the same
predictors as those found using the regression analysis. The
first split was made using the presence of one or more deep
white matter lesions, dividing the development dataset into a
group of 94 and 136 cases (Fig. 1). The risk of conversion
was 15% (14/94) in the left node without deep white matter
lesionsversus56%(76/136)intherightnodewithdeepwhite
matter lesions. A final split was made within the group with
deep white matter lesions, based on the presence of a
periventricular lesion. This split increased the risk of
conversion to 60% in the right lower node with a periven-
tricular lesion. When applied to the test set, this model
showedsensitivityof0.64(95%CI:0.48–0.78),specificityof
0.70 (95% CI: 0.59–0.80) and accuracy of 0.68 (95% CI:
0.59–0.76). No improvement in accuracy was found using
Random Forest analysis. Table 2 summarises the perfor-
mance of the modelsin the test set, including the original B/T
criteria. Similar to the regression analysis, including the total
number of lesions as an independent covariate resulted in a
tree with a single split based on the presence of four lesions
regardless of their topographical location.
Discussion
This study was fuelled by the desire to find MRI criteria for
dissemination in space in the initial MRI examination at
onset of CIS that are more sensitive than the existing B/T
criteria (without sacrificing specificity) and more simple to
Table 1 Clinical characteristics at onset of CIS
N=349
Mean age in years (range) 31 (10–52)
Sex (f/m ratio) 235/114
CIS presenting symptoms (%)
Optic neuritis 164 (47.0)
Spinal cord 80 (22.9)
Brainstem 64 (18.3)
Multiregional 21 (6.0)
Hemispheric 14 (4.0)
Undetermined 6 (1.7)
Median days from onset to MRI (IQR) 23 (10–49)
Fig. 1 Classification tree derived from the training set data. Values
represent number of CIS or CDMS cases. The predicted class is
displayed in each terminal node of the tree in bold
2246use. We took advantage of the large database available from
theMAGNIMScollaborativenetworkandappliedadvanced
statistical models. The predictors found were roughly in
agreement with those incriminated previously [2, 10–12].
While there was a slight increase in sensitivity (64% versus
49%) and the modelswere relatively simple, thiscame at the
costoftheslightlyreducedspecificity(70%versus79%)and
overall similar accuracy (68%) reported earlier for the B/T
criteria in this dataset [4]. More complicated models were
dismissed, since they tended to “over fit” the data, were
instable in the test set and would violate our desire to reduce
the complexity of the current B/Tcriteria.
The failure to achieve higher diagnostic accuracy using
information about dissemination inspacecriteriamayreflect
several problems inherent in a single brain MRI scan. First,
there are many diseases that may produce brain MRI lesions
similar to the type seen in MS that cannot be discriminated
usingsimpletopologicalandmorphologicalcriteria.Second,
incidental brain lesions increase with age (with or without
known risk factors), and without the additional use of spinal
cord imaging (where age-related changes do not occur) they
may interfere with the detection of MS lesions. Third, there
are a substantial number of patients without (substantial
numbersof)cerebralMRIlesions.Loweringthethresholdto
include such patients will interfere with specificity. Again,
spinalcordimagingmayprovide significantimprovement in
this group of patients.
Assuring a diagnosis of MS obviously does not simply
rely on demonstration of dissemination in space (using
MRI). Demonstration of dissemination in time is equally
important, and the IP criteria allow the use of MRI to this
end [1]. Using MRI information only, the relative weight
of dissemination in time is stronger than that obtained
from dissemination in space criteria [13]. In fact, when
dissemination in time is fulfilled, less stringent MRI criteria
for dissemination in space suffice, whilst guaranteeing
a high accuracy. In fact, two clinically silent lesions in
locations characteristic of MS (i.e. periventricular, juxtacor-
tical,infratentorialorspinalcord)performedverywellinthis
setting [13].
The strengths of our study included the large sample size
from a multi-centre study and the fact that all images were
evaluated by the same observer. Patients were recruited
from specialised centres and diagnosed by experienced
neurologists, resulting in a dataset with predominantly
young adults with clinically typical CIS. It may be viewed
as a weakness that other diagnoses had already been ruled
out before entry into this study. Other weaknesses are the
fact that gadolinium was not administered systematically
and that the spinal cord was not depicted.
In conclusion, with this approach we have not been able
to improve the diagnostic performance of the current B/T
criteria for dissemination in space alone using a single
unenhanced brain MRI examination. The combined use of
gadolinium-enhanced scans with simpler criteria for
dissemination in space and follow-up scans to ascertain
dissemination in time appears to be a more fruitful avenue.
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Table 2 Performance of the mod-
els in the test set including 95%
confidence intervals
*The B/T criteria did not include
data on enhancement status
Test dataset (n=119) Sensitivity Specificity Accuracy
B/T cutoff 3* 0.43 (0.28–0.59) 0.87 (0.77–0.94) 0.71 (0.62–0.79)
Regression analysis with cutoffs 0.43 (0.28–0.59) 0.82 (0.71–0.90) 0.68 (0.59–0.76)
Classification tree 0.64 (0.48–0.78) 0.70 (0.59–0.80) 0.68 (0.59–0.76)
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